Distribution of U.S. clinical and phase III pipeline 2013 by indication
This statistic depicts the distribution of U.S. clinical and phase III pipeline in 2013, by indication. Among all products in the clinical pipeline, some 37 percent were products concerning cancer. In phase III pipeline, the share of cancer products was 38 percent.